Leading Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing
Cannabis Law Report
JUNE 20, 2021
On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.
Let's personalize your content